NEW YORK (GenomeWeb News) – Trovagene today reported that its third-quarter revenues climbed to $211,000 from $55,000, as the firm nears the launch of its first molecular diagnostic tests.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PLOS this week: cell-free DNA from tumors is shorter than DNA from healthy cells, type 2 diabetes-related loci, and more.
Genetic analysis confirms that blood found on leaves collected near Marche-les-Dames some 80 years ago belongs to King Albert I of Belgium.
Researchers in the US begin to seek participants for the 1 million-person precision medicine cohort, the New York Times reports.
A new report indicates that women are underrepresented among US patent holders.